The MoU covers the following areas of cooperation:-
a. Research and development, active pharmaceutical ingredients (API) and IT-based medical equipment;
Human Resource Development;
c. Health services; and
d. Any other area as may be mutually agreed upon.
A Working Group will be set up to further elaborate the details of cooperation and to oversee the implementation of this MoU.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)